Info

Cengent Therapeutics provides a comprehensive suite of structural services and capabilities for accelerating and optimizing the drug discovery process. The company's technologies include: Genes To Leads® to accelerate and validate lead discovery; Structure Determination Services including augmented homology modeling and X-ray crystallography; and StructureBank®, a database for the comparative analysis of protein targets and anti-targets. April 01, 2005: Inncardio, Inc. Announces Acquisition of Cengent Therapeutics, Inc.